Sort
15,842 grants matching “pancreatic cancer”
ATF5 in the developing pancreas and survival functions in the mature beta cell.
$56,042Christine Juliana · University Of Pennsylvania · F32 · FY2015 · DK
Stroma Breaking Theranostic Nanoparticle for Targeted Pancreatic Cancer Therapy
$56,018Lily Yang · Emory University · U01 · FY2016 · CA
Stroma Breaking Theranostic Nanoparticle for Targeted Pancreatic Cancer Therapy
$56,018Lily Yang · Emory University · U01 · FY2017 · CA
SAMBAI: Societal, Ancestry, Molecular and Biological Analyses of Inequalities - University of Glasgow
$56,018Fieke Froeling · University Of Glasgow · OT2 · FY2024 · CA
Neurogeneic Amplification of Pancreatitis Pain
$56,000Karin N Westlund-High · University Of Kentucky · R01 · FY2009 · NS
Clinical protocols for the treatment of GI cancer
$55,934Tim Greten · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Multi-modal129 Xe Probes for Tumor Detection
$55,767Ivan Julian Dmochowski · University Of Pennsylvania · R21 · FY2006 · CA
Autophagy and human islet amyloid polypeptide in animal models of type 2 diabetes
$55,670Jacqueline Rivera · University Of California Los Angeles · F32 · FY2012 · DK
Pilot Project 5 - Pancreatic Treatment
$55,520Bo Han · University Of Southern California · U54 · FY2025 · CA
Small Animal Imaging
$55,462Stephen G Emerson · Columbia University Health Sciences · P30 · FY2014 · CA
BAG3 AS A REGULATOR OF CELL MOTILITY
$55,441Burnham Institute For Medical Research · R03 · FY2004 · CA
Pilot Project 5
$55,330Bo Han · University Of Southern California · U54 · FY2023 · CA
Cellular Response to cMet Endocytosis
$55,286Lisa A. Elferink · University Of Texas Med Br Galveston · R01 · FY2008 · CA
DNA repair alterations in metastatic prostate cancer: functional and therapeutic implications
$55,250Alan Ashworth · University Of California, San Francisco · R01 · FY2019 · CA
Alcohol abuse and Endoplasmic Reticulum dysfunction in exocrine pancreas
$55,175Aurelia Lugea · Brentwood Biomedical Research Institute · R01 · FY2013 · AA
Pilot for a Multicenter Case-Control Study of Pancreatic Cancer in a High Risk r*
$55,104Paul Joseph Brennan · International Agency For Res On Cancer · R03 · FY2007 · CA
Identifying STAT3 Co-dependencies in Cancer
$55,094Elsa Beyer Krall · Dana-Farber Cancer Inst · F32 · FY2014 · CA
Mechanisms of Lkb1 function in lymphocytes in the context of Kras activation
$55,094George P. Souroullas · Univ Of North Carolina Chapel Hill · F32 · FY2014 · HL
Understanding metabolic pathways that support redox homeostasis in cancer
$55,076Alexander Muir · Massachusetts Institute Of Technology · F32 · FY2018 · CA
Discovery of SATB2 Inhibitors for Pancreatic Cancer
$55,000Rakesh K. Srivastava · Glax, Llc · R03 · FY2025 · CA
Discovery of SATB2 Inhibitors for Pancreatic Cancer
$55,000Rakesh K. Srivastava · Glax, Llc · R03 · FY2024 · CA
Engineered TCR-Treg Cell Therapies Targeting Type 1 Diabetes Autoantigens
$55,000Matthew James Spindler · Gigamune, Inc. · R43 · FY2023 · AI
A novel glutaminase-free mammalian asparaginase with minimized immunogenicity to enable expanded use in cancer therapy
$55,000Hien-Anh Nguyen · Enzyme By Design, Inc. · R41 · FY2019 · CA
Translating a Novel Assay for Risk Stratification of Potentially Malignant Pancreatic Cystic Lesions
$55,000Daniel Sheik · Amplified Sciences Inc · R43 · FY2024 · CA
A novel dual-carrier ultrasmall nanomedicine for the treatment of stroma-rich pancreatic cancer
$55,000Katherine Marie Eichinger · Duo Oncology Inc · R41 · FY2024 · CA